Latest filing published 04 Jun 2026 for AVITA Medical, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeremy Curnock Cook is a declared insider at 3 companies; the most frequent names are Armata Pharmaceuticals, Inc., Osteologix, Inc. and AVITA Medical, Inc. In total, 29 filings cover trades dated from 2 January 2007 to 20 January 2026.
In open-market terms, that means 7 purchases worth €983k on one side and 2 sales worth €57k on the other. The amount is not disclosed for 4 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 19 share grants.
In size, the median ticket on the buying side is €325k.
The latest filing, published on 4 June 2026, reports a share grant in AVITA Medical, Inc. The latest purchase dates back some time: it was published 3,133 days ago, on 26 March 2018. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations